Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GPI transamidase component PIG-T (PIGT) is an essential type-I transmembrane protein that forms part of the GPI transamidase enzyme complex in the endoplasmic reticulum. This complex catalyzes the posttranslational attachment of glycosylphosphatidylinositol (GPI) anchors to a wide variety of cell surface proteins, a process required for their proper localization and function. PIG-T specifically stabilizes and maintains the multi-protein complex by associating with other subunits, ensuring correct assembly for GPI anchor transfer. Mutations in the PIGT gene underlie severe congenital disorders affecting blood, nerve, and immune cells, including rare forms of paroxysmal nocturnal hemoglobinuria and congenital disorders of glycosylation. No known drugs directly target this molecule; its essential role is structural and regulatory in protein complex formation rather than being a direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GPI transamidase component PIG-T (PIGT).